H.Res. 484 · 117th Congress · House

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Active· Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Introduced
Jun 17, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Bill Text Versions

1

Introduced in House

Published: June 17, 2021

USLM Available
View Text